SAGE Therapeutics (SAGE) Misses Q2 EPS by 21c
Tweet
Share
E-mail
SAGE Therapeutics (NASDAQ: SAGE) reported Q2 EPS of ($1.88), $0.21 worse than the analyst estimate of ($1.67).
For earnings history and earnings-related data on SAGE Therapeutics (SAGE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- BofA Securities Starts APL Apollo Tubes Ltd (APAT:IN) at Buy
- Freedom Broker Starts Unity Bancorp (UNTY) at Hold
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
